SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920199 SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
57 GF Score
Price ¥27.12
GF Value ¥17.98
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SiChuan Qian Li Beoka Medical Technology Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

SiChuan Qian Li Beoka Medical Technology Co Valuation Rank Related Terms

BJSE:920199
57GF Score
SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Overvalued in 2026?

Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co stock appears to be overvalued. The current stock price of ¥27.12 is trading 50.8% above its estimated GF Value™ of ¥17.98. GuruFocus considers SiChuan Qian Li Beoka Medical Technology Co to be Significantly Overvalued.

Key valuation signals for BJSE:920199:

  • Valuation Rank:
  • GF Value™: ¥17.98 vs. price of ¥27.12 (50.8% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SiChuan Qian Li Beoka Medical Technology Co Business Description

Address East Third Ring Road, Longtan Industrial Park, Section 2, Chenghua District, Sichuan Province, Chengdu City, CHN, 610052
SiChuan Qian Li Beoka Medical Technology Co Ltd is an intelligent rehabilitation equipment manufacturer integrating research, development, production, sales, and service. Its product series comprises the Electrotherapy series, Heat therapy series, Force therapy series, Spa series, and Oxygen therapy series.
57GF Score

Get the complete analysis for BJSE:920199

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.12
Price
¥17.98
GF Value